Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc., which operates as a housing and medical facility real estate investment trust (REIT), has demonstrated a strong financial outlook with raised normalized funds from operations (NFFO) estimates, reflecting a positive response to the company’s second-quarter performance and management's guidance. The updated projections indicate a year-over-year normalized FFO per share growth of 5.3% for 2025, escalating to 4.8% growth in 2026, suggesting sustained momentum in the company's financial performance. These improvements align with favorable adjustments in both 2025 and 2026 NFFO estimates, reinforcing confidence in the company's ability to deliver solid returns.

Bears say

National Health Investors Inc. is projected to experience lower earnings growth in the coming years, primarily due to challenges related to operator transitions and potential issues affecting revenue generation. The company's performance may be further hampered by uncertainties surrounding the NHC rent reset, which could fall below investor expectations, along with the risk of weaker deferred rent collections. Additionally, the possibility of operational disruptions arising from external factors, such as another pandemic, could adversely impact the performance of one or more operators, contributing to a negative outlook for the company's stock.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.